日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry

在对JAK抑制剂反应不足的类风湿关节炎患者中，改用生物制剂DMARDs与JAK抑制剂轮换治疗的疗效比较：来自FIRST注册研究

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2024-004987
Miyazaki, Yusuke; Nakayamada, Shingo; Tanaka, Hiroaki; Hanami, Kentaro; Fukuyo, Shunsuke; Kubo, Satoshi; Yamaguchi, Ayako; Miyagawa, Ippei; Satoh-Kanda, Yurie; Todoroki, Yasuyuki; Inoue, Yoshino; Ueno, Masanobu; Tanaka, Yoshiya
JAK/STAT
关节炎
发表日期：2025
文献求助 收藏

Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes

更正：古塞库单抗和阿达木单抗治疗脓疱性关节骨炎的疗效和安全性及其对外周血免疫表型的影响

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-023-03005-x
Ueno, Masanobu; Miyagawa, Ippei; Miyazaki, Yusuke; Hanami, Kentaro; Fukuyo, Shunsuke; Kubo, Satoshi; Nakayamada, Shingo; Tanaka, Yoshiya
免疫/内分泌
发表日期：2023
文献求助 收藏

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry

类风湿性关节炎患者分子靶向治疗的代际依赖性维持率和停药原因：来自 FIRST 注册研究

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00603-8
Kubo, Satoshi; Miyazaki, Yusuke; Todoroki, Yasuyuki; Nagayasu, Atsushi; Kanda, Ryuichiro; Aritomi, Takafumi; Matsunaga, Satsuki; Ueno, Masanobu; Miyagawa, Ippei; Sonomoto, Koshiro; Hanami, Kentaro; Nakayamada, Shingo; Tanaka, Yoshiya
关节炎
发表日期：2023
文献求助 收藏

Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease

嗜酸性肉芽肿性血管炎在组织中表现出T细胞活化和IgG4免疫反应；与IgG4相关疾病的比较

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2021-002086
Kubo, Satoshi; Kanda, Ryuichiro; Nawata, Aya; Miyazaki, Yusuke; Kawabe, Akio; Hanami, Kentaro; Nakatsuka, Keisuke; Saito, Kazuyoshi; Nakayamada, Shingo; Tanaka, Yoshiya
T细胞
炎症/感染
IgG
T细胞
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study

美泊利单抗治疗嗜酸性肉芽肿性血管炎缓解诱导治疗的安全性和有效性：一项回顾性研究

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-022-02845-3
Ueno, Masanobu; Miyagawa, Ippei; Aritomi, Takafumi; Kimura, Koichi; Iwata, Shigeru; Hanami, Kentaro; Fukuyo, Syunsuke; Kubo, Satoshi; Miyazaki, Yusuke; Nakayamada, Shingo; Tanaka, Yoshiya
炎症/感染
发表日期：2022
文献求助 收藏

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.

TSUBAME 研究显示，在类风湿性关节炎患者接受 certolizumab pegol 治疗 24 小时后，血清 TNFα 水平可预测治疗 12 周的疗效

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-021-02547-2
Miyazaki Yusuke, Nakano Kazuhisa, Nakayamada Shingo, Kubo Satoshi, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Miyagawa Ippei, Yamaguchi Ayako, Kawabe Akio, Saito Kazuyoshi, Tanaka Yoshiya
炎症/感染
关节炎
炎症
发表日期：2021
文献求助 收藏

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease

比较皮质类固醇单药治疗与TNF抑制剂联合或不联合皮质类固醇治疗难治性肠型白塞病患者的疗效

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-019-1933-8
Miyagawa, Ippei; Nakano, Kazuhisa; Iwata, Shigeru; Nakayamada, Shingo; Saito, Kazuyoshi; Hanami, Kentaro; Fukuyo, Shunsuke; Kubo, Satoshi; Kawabe, Akio; Miyazaki, Yusuke; Tanaka, Yoshiya
发表日期：2019
文献求助 收藏

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

在已确诊类风湿关节炎患者病情缓解后停止使用阿达木单抗：HONOR 研究的 1 年结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2013-204016
Tanaka, Yoshiya; Hirata, Shintaro; Kubo, Satoshi; Fukuyo, Shunsuke; Hanami, Kentaro; Sawamukai, Norifumi; Nakano, Kazuhisa; Nakayamada, Shingo; Yamaoka, Kunihiro; Sawamura, Fusae; Saito, Kazuyoshi
关节炎
发表日期：2015
文献求助 收藏

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab

血清 14-3-3η 水平与类风湿关节炎的严重程度和临床结局相关，其治疗前水平可预测托珠单抗治疗后的 DAS28 缓解情况。

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-015-0799-7
Hirata, Shintaro; Marotta, Anthony; Gui, Yuan; Hanami, Kentaro; Tanaka, Yoshiya
关节炎
发表日期：2015
文献求助 收藏

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study

托珠单抗治疗类风湿性关节炎患者的临床、影像学和功能疗效——REACTION 52周研究

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/ker221
Takeuchi, Tsutomu; Tanaka, Yoshiya; Amano, Koichi; Hoshi, Daisuke; Nawata, Masao; Nagasawa, Hayato; Sato, Eri; Saito, Kazuyoshi; Kaneko, Yuko; Fukuyo, Shunsuke; Kurasawa, Takahiko; Hanami, Kentaro; Kameda, Hideto; Yamanaka, Hisashi
关节炎
发表日期：2011
文献求助 收藏